GH1 and acromegaly: They recommended using IGF-I normalized to age but not sex for the diagnosis of acromegaly, confirmed by lack of suppression of GH < 1 μg/L during OGTT if necessary, and to use age-normalized IGF-I and random GH < 1.0 μg/L as a therapeutic goal.